Home > News > Kereos Technology Specifically Targets Arterial Plaque
September 29th, 2006
Kereos Technology Specifically Targets Arterial Plaque
Abstract:
Kereos, a biotechnology company developing highly targeted diagnostic and therapeutic approaches to cancer and cardiovascular disease, announced today the publication of a preclinical study showing the ability of Kereos' technology to detect and treat atherosclerotic plaque, a primary cause of heart attack and stroke.
Source:
genengnews.com
Related News Press |
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Materials/Metamaterials/Magnetoresistance
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||